Biden's performance criticized, questions raised over decision to prioritize race for COVID drugs

THE VILLAGES, Fla. – Some Americans questioned recent guidance the Biden administration issued stating that race or ethnicity could place patients at high risk of severe COVID-19 infection and more quickly qualify them for monoclonal antibodies and oral antiviral medications. 

"We're all in it, the virus is a virus, and you can get it no matter what you are," Ben told Fox News. 

Dave, a Democrat from Massachusetts, said he thinks medicine should be available for everyone.

"I don't see why race is always mentioned nowadays," Dave said. "You walk into a clinic, you should get taken care of. Whether you're Black, White, Indian, Japanese, whatever your nationality is, it shouldn't matter."